MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2021-22)
- Udyam number
- UDYAM-OD-07-0018130
Jixon Pharmaceuticals Private Limited
Jixon Pharmaceuticals Private Limited - pharma in Cuttack, Odisha, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹1.22 Cr
▲ 10% YoY
Net profit · FY 2023
₹1.59 Lakh
Net margin 1.3%
EBITDA · FY 2023
₹2.15 Lakh
EBITDA margin 1.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Open charges
₹10.01 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
13
Provident fund records
About Jixon Pharmaceuticals Private Limited
Data last updated:
Jixon Pharmaceuticals Private Limited is a private limited company based in Cuttack, Odisha, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U33309OR2016PTC025471. Its GSTIN is 21AADCJ7479G1ZH (Odisha).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Surendra Kumar Behera and Rashmi Ranjan Behera.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Barik Sahi Sankarpur, Cuttack, Odisha, India – 753012.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.22 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.59 Lakh (net margin 1.3%) and EBITDA of ₹2.15 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 62% over five years.
The company has about 13 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10.01 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
Jixon Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-OD-07-0018130). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U33309OR2016PTC025471
Registration Number 025471
Incorporation Date 04 July 2016
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-OD-07-0018130
Recognitions & Rankings of Jixon Pharmaceuticals
Contact details
Jixon Pharmaceuticals Private Limited's registered office is in Cuttack, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressBarik Sahi Sankarpur, Cuttack, Odisha, India – 753012
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Jixon Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Jixon Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Jixon Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Jixon Pharmaceuticals Private Limited, buy the company report.
Financials of Jixon Pharmaceuticals Private Limited
FY 2023 filings availableJixon Pharmaceuticals Private Limited reported revenue of ₹1.22 Cr (up 10% YoY) for FY 2023.
Revenue · FY 2023
₹1.22 Cr ▲ 10%
Net profit · FY 2023
₹1.59 Lakh margin 1.3%
EBITDA · FY 2023
₹2.15 Lakh margin 1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 36%
5 years · compounded
▲ 62%
EBITDA CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 116%
5 years · compounded
▲ 154%
Revenue has grown at a compounded annual rate (CAGR) of 62% over five years, including 10% growth in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.15 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.59 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jixon Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jixon Pharmaceuticals Private Limited
Jixon Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surendra Kumar Behera | Director | 04 Jul 2016 | 10 Years 3 Months | Current |
| Rashmi Ranjan Behera | Director | 29 Sep 2017 | 9 Years 1 Months | Current |
Auditor
Jixon Pharmaceuticals Private Limited is audited by ROUTRAY & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ROUTRAY & CO | FY 2019 | 329060E |
Shareholding
The shareholding of Jixon Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Jixon Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.01 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 May 2021 | 100447468 | Axis Bank Limited | ₹10.01 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Jixon Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Total cases
2
Filed against the company
2
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Lendingkart Finance Limited | Pending |
| District court, Solan, Himachal Pradesh | Cheque dishonour complaint | Filed against the company by M/S Sigma Softgel and Formulation, | Pending |
To see the full case history of Jixon Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jixon Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Jixon Pharmaceuticals Private Limited has a workforce of 13 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
13
Active EPFO establishments
1
Employee growth
30%
GST
Jixon Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 21AADCJ7479G1ZH | Odisha | Active | 20 Oct 2017 |
To see the full GST registrations and return filing status of Jixon Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jixon Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Madhusmita Sahoo ceased to be Director on 29 Sep 2017.
AGM
Jixon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Jixon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Cuttack.
Charges
A charge with Axis Bank Limited amounted to Rs. 10.01 Lakh with Charge ID 100447468 was registered on 17 May 2021.
Ceased
Madhusmita Sahoo ceased to be Director.
Appointed
Rashmi Ranjan Behera was appointed as Director.
Ceased
Rajesh Kumar Sahoo ceased to be Director.
Appointed
Surendra Kumar Behera was appointed as Director.
Incorporation
04 Jul 2016
Jixon Pharmaceuticals Private Limited was registered on 04 Jul 2016 with Roc Cuttack & aged 10 years 3 months as per MCA records.
Frequently asked questions
Jixon Pharmaceuticals is an active private limited company based in Cuttack, Odisha, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 July 2016 (10+ years old) and is registered under CIN U33309OR2016PTC025471.
Jixon Pharmaceuticals has 2 current directors:
- Surendra Kumar Behera - Director
- Rashmi Ranjan Behera - Director
The latest financial statements of Jixon Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Jixon Pharmaceuticals is 21AADCJ7479G1ZH, registered in Odisha.
The CIN (Corporate Identification Number) of Jixon Pharmaceuticals is U33309OR2016PTC025471. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jixon Pharmaceuticals has 2 court cases on record: 2 filed against it. 2 are pending.
Jixon Pharmaceuticals was incorporated on 04 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Cuttack.
Madhusmita Sahoo ceased to be Director on 29 Sep 2017. Rashmi Ranjan Behera was appointed as Director on 29 Sep 2017. Rajesh Kumar Sahoo ceased to be Director on 20 Jun 2017. Jixon Pharmaceuticals has 4 board changes on record in total.
Yes, Jixon Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-OD-07-0018130).
The registered office of Jixon Pharmaceuticals is at Barik Sahi Sankarpur, Cuttack, Odisha, India – 753012.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages